Global Phage Therapy Market Growth (Status and Outlook) 2023-2029

Global Phage Therapy Market Growth (Status and Outlook) 2023-2029

Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
LPI (LP Information)' newest research report, the “Phage Therapy Industry Forecast” looks at past sales and reviews total world Phage Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Phage Therapy sales for 2023 through 2029. With Phage Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Phage Therapy industry.
This Insight Report provides a comprehensive analysis of the global Phage Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Phage Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Phage Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Phage Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Phage Therapy.
The global Phage Therapy market size is projected to grow from US$ 31 million in 2022 to US$ 101.3 million in 2029; it is expected to grow at a CAGR of 18.3% from 2023 to 2029.
The major players in global Phage Therapy market include NPO Microgen, Proteon Pharmaceuticals, Phagelux, etc. The top 3 players occupy about 25% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. DsDNA Bacteriophage is the main type, with a share over 90%. Animal Health is the main application, which holds a share about 55%.
This report presents a comprehensive overview, market shares, and growth opportunities of Phage Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Segmentation by application
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences,Inc
Pharmex Group,LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage

Please note: The report will take approximately 2 business days to prepare and deliver.